Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00142168
Status:
TERMINATED
Last Update Posted:
2016-04-21
First Post:
2005-09-01
Brief Title:
CC-5013 Lenalidomide and Rituximab in Waldenstroms Macroglobulinemia
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-09
Start Date Type:
None
Primary Completion Date:
2006-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-04
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-01
First Submit QC Date:
September 1 2005
Study First Post Date:
2005-09-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2015-12-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-03-23
Last Update Post Date:
2016-04-21
Last Update Post Date Type:
ESTIMATED